CE2024-01-18T12:15:51
Challenges such as market exclusivity and patient treatment preference are expected to shape the insomnia and Gaucher disease therapy landscape in the seven major markets (7MM) in 2032, research predicts.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-10-27T10:14:00Z
Sponsored by Capsugel
2026-10-22T10:54:00Z
2026-10-21T11:35:00Z
2026-10-19T13:13:00Z
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
2026-09-01T11:25:00
Sponsored by Raytec
2026-08-27T14:30:00
Sponsored by Waters Corporation
2026-09-23T09:00:00
Sponsored by Testo Saveris GmbH
Site powered by Webvision Cloud